New drug shows promise in shrinking fatty liver
NCT ID NCT06482112
First seen Jun 02, 2026 · Last updated Jun 11, 2026 · Updated 2 times
Summary
This study tested a drug called efinopegdutide in 124 adults with a type of fatty liver disease (MASLD). The goal was to see if taking the drug every two weeks or every week could safely reduce fat in the liver over 28 weeks. The study also looked at weight loss and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AGA Clinical Trials ( Site 0274)
Hialeah, Florida, 33012, United States
-
Acclaim Clinical Research ( Site 0241)
San Diego, California, 92120, United States
-
American Research Corporation ( Site 0234)
San Antonio, Texas, 78215, United States
-
Arizona Liver Health ( Site 0211)
Tucson, Arizona, 85712, United States
-
Basil Clinical ( Site 0246)
Inwood, New York, 11096, United States
-
California Liver Research Institute ( Site 0216)
Pasadena, California, 91105, United States
-
Clinical Trials of Texas, LLC-Clinical Research ( Site 0252)
San Antonio, Texas, 78229, United States
-
Del Sol Research Management, LLC ( Site 0209)
Tucson, Arizona, 85715, United States
-
Excel Clinical Research, LLC ( Site 0200)
Las Vegas, Nevada, 89109, United States
-
Excel Medical Clinical Trials ( Site 0268)
Boca Raton, Florida, 33434, United States
-
Floridian Clinical Research, LLC ( Site 0208)
Miami Lakes, Florida, 33016, United States
-
Gastroenterology and Liver Institute ( Site 0263)
Escondido, California, 92025, United States
-
Homestead Associates in Research, Inc. ( Site 0243)
Homestead, Florida, 33033, United States
-
Houston Research Institute ( Site 0221)
Houston, Texas, 77079, United States
-
Impact Research Institute ( Site 0227)
Waco, Texas, 76710, United States
-
Klinical Investigations Group-Clinical Research ( Site 0100)
San Juan, 00909, Puerto Rico
-
Lucas Research, Inc ( Site 0204)
Morehead City, North Carolina, 28557, United States
-
Neoclinical Research ( Site 0275)
Hialeah, Florida, 33016, United States
-
Olympus Family Medicine/CCT Research ( Site 0266)
Holladay, Utah, 84117, United States
-
Om Research LLC ( Site 0207)
Camarillo, California, 93012, United States
-
Pan American Center for Oncology Trials - Ciudadela ( Site 0101)
San Juan, 00909, Puerto Rico
-
Pinnacle Clinical Research ( Site 0203)
Austin, Texas, 78757, United States
-
Pinnacle Clinical Research-Clinical Research Coordination ( Site 0229)
San Antonio, Texas, 78229, United States
-
Pinnacle Clinical Research-Corpus Christi ( Site 0267)
Corpus Christi, Texas, 78404, United States
-
San Juan Bautista School of Medicine - Clinical Research Unit ( Site 0104)
Caguas, 00726, Puerto Rico
-
South Ogden Family Medicine/ CCT Research ( Site 0255)
South Ogden, Utah, 84405, United States
-
South Texas Research Institute ( Site 0226)
Edinburg, Texas, 78539, United States
-
Southeast Clinical Research Center ( Site 0223)
Dalton, Georgia, 30720, United States
-
Texas Clinical Research Institute ( Site 0230)
Arlington, Texas, 76012, United States
-
The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0
Chandler, Arizona, 85224, United States
-
The Institute for Liver Health II dba Arizona Liver Health - Peoria ( Site 0224)
Peoria, Arizona, 85381, United States
-
The Machuca Foundation ( Site 0218)
Las Vegas, Nevada, 89101, United States
-
Velocity Clinical Research Rockville ( Site 0245)
Rockville, Maryland, 20854, United States
-
Velocity Clinical Research, Austin ( Site 0201)
Austin, Texas, 78759, United States
-
Velocity Clinical Research, Gardena ( Site 0235)
Gardena, California, 90247, United States
-
Velocity Clinical Research, Huntington Park ( Site 0210)
Huntington Park, California, 90255, United States
-
Velocity Clinical Research, Panorama City ( Site 0228)
Van Nuys, California, 91405, United States
-
Velocity Clinical Research, Santa Ana ( Site 0250)
Santa Ana, California, 92704, United States
-
Zenos Clinical Research ( Site 0240)
Dallas, Texas, 75230, United States
Conditions
Explore the condition pages connected to this study.